Holen Sie sich die Stockscreener-App
0.3498
6.53%
-0.0054
Schlusskurs vom Vortag:
$0.3552
Offen:
$0.331
24-Stunden-Volumen:
9,666
Relative Volume:
0.05
Marktkapitalisierung:
$12.17M
Einnahmen:
$7.11M
Nettoeinkommen (Verlust:
$-41.28M
KGV:
-0.2535
EPS:
-1.38
Netto-Cashflow:
$-26.84M
1W Leistung:
-5.17%
1M Leistung:
-27.98%
6M Leistung:
-73.86%
1J Leistung:
-71.13%
1-Tages-Spanne:
$0.33
$0.3716
1-Wochen-Bereich:
$0.32
$0.3716
52-Wochen-Spanne:
$0.2801
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
Firmenname
Co Diagnostics Inc
Sektor
Branche
Telefon
(801) 278-9769
Adresse
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Vergleichen Sie CODX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.341 | 12.17M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
131.47 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.15 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.40 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.08 | 104.24B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.20 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-12 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-12-29 | Eingeleitet | Sidoti | Buy |
| 2021-03-29 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-05-20 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results - Seeking Alpha
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance
Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN
Co-Diagnostics Earnings Call: Progress Amid Challenges - MSN
HC Wainwright Lowers Co-Diagnostics (NASDAQ:CODX) Price Target to $1.00 - Defense World
Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics sees revenue dip, losses deepen in Q4 2024 By Investing.com - Investing.com South Africa
Co-Diagnostics operating loss hits USD 40.1M in FY 24 - Medical Buyer
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navi - GuruFocus
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Co-Diagnostics Reports 2024 Financial Results and Strategic Progress - TipRanks
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - Lelezard
Co-Diagnostics Inc Reports $3.9 Million Revenue and $1.24 EPS Lo - GuruFocus
Co-Diagnostics earnings missed by $0.03, revenue fell short of estimates - Investing.com
Co-Diagnostics (CODX) Highlights 2024 Earnings and Strategic Dev - GuruFocus
Earnings call transcript: Co-Diagnostics sees revenue dip, losses deepen in Q4 2024 - Investing.com India
Co-Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results – Company Announcement - Financial Times
Uncovering Potential: Co-Diagnostics's Earnings Preview - Benzinga
Co-Diagnostics stock hits 52-week low at $0.43 amid market challenges - Investing.com Australia
Co-Diagnostics stock hits 52-week low at $0.43 amid market challenges By Investing.com - Investing.com South Africa
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Co-Diagnostics, Inc. Investors of Important Deadline in Securities Class Action – CODX - Business Wire
Co-Diagnostics (CODX) Projected to Post Earnings on Thursday - Defense World
Litigators of the Week: Summary Judgment Win For COVID Test Maker in Securities Fraud Suit Targeting Accuracy Claims - Law.com
Co-Diagnostics stock hits 52-week low at $0.45 amid market challenges - Investing.com Australia
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Co-Diagnostics, Inc. (CODX) and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire
Co-Diagnostics stock hits 52-week low at $0.45 amid market challenges By Investing.com - Investing.com South Africa
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - BioSpace
Co-Diagnostics Sets Date for Crucial Year-End 2024 Financial Results - Stock Titan
Co-Diagnostics Inc.’s Securities Class Action - Global Legal Chronicle
Co-Diagnostics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Co-Diagnostics wins dismissal of class action lawsuit - TipRanks
Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit - PR Newswire
Covid Test Maker Beats Investor Suit Over ‘100% Accurate’ Claim - Bloomberg Law News
Analyzing ResMed (NYSE:RMD) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges - Investing.com Australia
Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
Finanzdaten der Co Diagnostics Inc-Aktie (CODX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):